Europe — EMA
Oxaliplatin Accord
Oxaliplatin, the active ingredient in Oxaliplatin Accord, is a platinum compound presented as a unknown/unknown for intravenous use. It treats colorectal cancer and may be used in other oncology settings.
Request sourcing
1
Pack/s
What is Oxaliplatin?
Oxaliplatin, the active ingredient in Oxaliplatin Accord, is a platinum compound presented as a unknown/unknown for intravenous use. It treats colorectal cancer and may be used in other oncology settings.
GNH USA supplies Oxaliplatin Accord as a licensed, GDP‑compliant international pharmaceutical supplier of hospitals and oncology centres worldwide.
What is Oxaliplatin used for?
Oxaliplatin Accord ... ... ... ... ... ... ... ... ... ... ... ... ...
Product details
Drug
Oxaliplatin
Route
Intravenous Use
Manufacturer
Accord Healthcare Polska Sp. Z O.O.
Origin
EU
Related products

Oxaliplatin 50 mg/10mL
Oxaliplatin · 50 mg/10 mL
Oxaliplatin
INJECTION, SOLUTION, CONCENTRATE
Teva Parenteral Medicines, Inc.
USA

Oxaliplatin 100 mg/20mL
Oxaliplatin · 100 mg/20 mL
Oxaliplatin
INJECTION, SOLUTION, CONCENTRATE
Teva Parenteral Medicines, Inc.
USA

Oxaliplatin 5 mg/mL
Oxaliplatin · 5 mg/mL
Oxaliplatin
INJECTION, SOLUTION
Sandoz Inc
USA

Oxaliplatin 5 mg/mL
Oxaliplatin · 5 mg/mL
Oxaliplatin
INJECTION, SOLUTION
Sandoz Inc
USA